Main Session
Sep
29
SS 41 - Optimizing Radiation Therapy in Gynecologic Cancers: Fractionation, Targeting, and Toxicity Reduction
326 - MRI-Guided Pelvic Active Bone Marrow Sparing Intensity Modulated Radiotherapy Reduces the Incidence of the Hematologic Toxicity of Patients with Cervical Cancer: A Single-Center Prospective Randomized Controlled Trial
Presenter(s)
Fang Wu, MD, PhD - The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi